Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-120982
Filing Date
2024-11-05
Accepted
2024-11-04 18:25:00
Documents
65
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vrca-20240930.htm   iXBRL 10-Q 1610214
2 EX-10.1 vrca-ex10_1.htm EX-10.1 67326
3 EX-10.2 vrca-ex10_2.htm EX-10.2 139285
4 EX-31.1 vrca-ex31_1.htm EX-31.1 14522
5 EX-32.1 vrca-ex32_1.htm EX-32.1 10581
  Complete submission text file 0000950170-24-120982.txt   7273717

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT vrca-20240930.xsd EX-101.SCH 1260891
68 EXTRACTED XBRL INSTANCE DOCUMENT vrca-20240930_htm.xml XML 982735
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

EIN.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38529 | Film No.: 241425035
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)